Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study

MLA

Parisi, S., et al. Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313115380&authtype=sso&custid=ns315887.

APA

Parisi, S., Becciolini, A., Ditto, M., Rozza, D., Zanetti, A., Lagana, A., Peroni, C., Centanaro Di Vittorio, C., Degiovanni, R., Realmuto, C., Scire, C., Priora, M., Di Donato, E., Santilli, D., Mozzani, F., Lucchini, G., Ariani, A., Gardelli, L., Girelli, F., … Fusaro E. (2022). Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study.

Chicago

Parisi, S, A Becciolini, M Ditto, D Rozza, A Zanetti, A Lagana, C Peroni, et al. 2022. “Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313115380&authtype=sso&custid=ns315887.